Log in

Relevant bibliographies by topics / Renal Protection / Journal articles

To see the other types of publications on this topic, follow the link: Renal Protection.

Journal articles on the topic 'Renal Protection'

Author: Grafiati

Published: 7 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Renal Protection.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Mogensen, Carl Erik. "Renal protection." American Journal of Cardiovascular Drugs 4, Special Issue 1 (2004): 31–36. http://dx.doi.org/10.2165/00129784-200404991-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Sadovnikoff, Nicholas, and Simon Gelman. "Renal protection." Best Practice & Research Clinical Anaesthesiology 14, no. 1 (2000): 161–71. http://dx.doi.org/10.1053/bean.2000.0068.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sadovnikoff, Nicholas, and Simon Gelman. "Perioperative renal protection." Current Opinion in Anaesthesiology 12, no. 3 (1999): 337–41. http://dx.doi.org/10.1097/00001503-199906000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Canet, Emmanuel, and Rinaldo Bellomo. "Perioperative renal protection." Current Opinion in Critical Care 24, no. 6 (2018): 568–74. http://dx.doi.org/10.1097/mcc.0000000000000560.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Webb, Stephen T., and J. Stephen D. Allen. "Perioperative renal protection." Continuing Education in Anaesthesia Critical Care & Pain 8, no. 5 (2008): 176–80. http://dx.doi.org/10.1093/bjaceaccp/mkn032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Jones, Dean R., and H. Thomas Lee. "Perioperative renal protection." Best Practice & Research Clinical Anaesthesiology 22, no. 1 (2008): 193–208. http://dx.doi.org/10.1016/j.bpa.2007.08.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Rodicio, Jose L., and Luis M. Ruilope. "Assessing renal effects and renal protection." Journal of Hypertension 13, supplement4 (1995): S19—S25. http://dx.doi.org/10.1097/00004872-199512002-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Ruiz-Hurtado, Gema, and Luis M. Ruilope. "Does cardiovascular protection translate into renal protection?" Nature Reviews Cardiology 11, no. 12 (2014): 742–46. http://dx.doi.org/10.1038/nrcardio.2014.97.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

UEKI, Masaaki. "Renal Protection Strategy for Ischemic Renal Dysfunction." JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 27, no. 7 (2007): 608–12. http://dx.doi.org/10.2199/jjsca.27.608.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hoss, Molly, and Corey Lyon. "Empagliflozin for renal protection." Evidence-Based Practice 20, no. 8 (2017): E12. http://dx.doi.org/10.1097/01.ebp.0000541808.45899.70.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Maleck, Wolfgang H., Swen N. Piper, and Katharina P. Koetter. "Dopamine for renal protection." Canadian Journal of Anesthesia/Journal canadien d'anesthésie 50, no. 1 (2003): 93–94. http://dx.doi.org/10.1007/bf03020198.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Hashiguchi, Hideo, Hiroaki Morooka, and Koji Sumikawa. "Renal Protection with Isoflurane." Anesthesia & Analgesia 103, no. 4 (2006): 1054. http://dx.doi.org/10.1213/01.ane.0000239082.25563.06.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Lee, H. Thomas, and Charles W. Emala. "Renal Protection with Isoflurane." Anesthesia & Analgesia 103, no. 4 (2006): 1053–54. http://dx.doi.org/10.1213/01.ane.0000239084.72741.b2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Amir, Rawan, Sara Suhl, and Charles M. Alexander. "Renal Evaluation and Protection." Clinics in Geriatric Medicine 36, no. 3 (2020): 431–45. http://dx.doi.org/10.1016/j.cger.2020.04.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Di Tomasso, Nora, Fabrizio Monaco, and Giovanni Landoni. "Renal protection in cardiovascular surgery." F1000Research 5 (March 11, 2016): 331. http://dx.doi.org/10.12688/f1000research.7348.1.

Full text

Abstract:

Acute kidney injury (AKI) is one of the most relevant complications after major surgery and is a predictor of mortality. In Western countries, patients at risk of developing AKI are mainly those undergoing cardiovascular surgical procedures. In this category of patients, AKI depends on a multifactorial etiology, including low ejection fraction, use of contrast media, hemodynamic instability, cardiopulmonary bypass, and bleeding. Despite a growing body of literature, the treatment of renal failure remains mainly supportive (e.g. hemodynamic stability, fluid management, and avoidance of further

APA, Harvard, Vancouver, ISO, and other styles

16

MacIsaac, Richard J., George Jerums, and Elif I. Ekinci. "Cardio-renal protection with empagliflozin." Annals of Translational Medicine 4, no. 20 (2016): 409. http://dx.doi.org/10.21037/atm.2016.10.36.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Mori, Takefumi, Ikuko Yabana, Satoshi Kinugasa, Shinichi Sato, and Yoshitsugu Iwakura. "Renal protection on ascites control." Kanzo 58, no. 2 (2017): 78–84. http://dx.doi.org/10.2957/kanzo.58.78.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Salvetti, Antonio, Paola Mattei, and Isabella Sudano. "Renal Protection and Antihypertensive Drugs." Drugs 57, no. 5 (1999): 665–93. http://dx.doi.org/10.2165/00003495-199957050-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Shehabi, Y. "Renal protection by N -acetylcysteine." British Journal of Anaesthesia 98, no. 2 (2007): 270–71. http://dx.doi.org/10.1093/bja/ael351.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Benigni, Ariela, Norberto Perico, and Giuseppe Remuzzi. "Endothelin Antagonists and Renal Protection." Journal of Cardiovascular Pharmacology 35 (2000): S75—S78. http://dx.doi.org/10.1097/00005344-200000002-00017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Rodicio, Jose L., Jose M. Morales, Jose M. Alcazar, and Luis M. Ruilope. "Calcium antagonists and renal protection." Journal of Hypertension 11, Supplement 1 (1993): S49—S53. http://dx.doi.org/10.1097/00004872-199303001-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Redon, Josep. "Renal protection by antihypertensive drugs." Journal of Hypertension 16, Supplement (1998): 2091–100. http://dx.doi.org/10.1097/00004872-199816121-00035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Gelman, Simon. "Renal protection during surgical stress." Acta Anaesthesiologica Scandinavica 41, S110 (1997): 43–45. http://dx.doi.org/10.1111/j.1399-6576.1997.tb05495.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Rocca, Giorgio Della, Livia Pompei, Silvio Monaco, Maria Gabriella Costa, and Cecilia Coccia. "Renal Protection and Liver Transplantation." Anesthesiology 96, Sup 2 (2002): A415. http://dx.doi.org/10.1097/00000542-200209002-00415.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Tervaert, Jan-Willem Cohen, and Peter W. de Leeuw. "Renal protection from glomerular fibrosis." Journal of Hypertension 21, no. 4 (2003): 687–89. http://dx.doi.org/10.1097/00004872-200304000-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Wang, Si-Yang, Guang-Yan Cai, and Xiang-Mei Chen. "Energy restriction in renal protection." British Journal of Nutrition 120, no. 10 (2018): 1149–58. http://dx.doi.org/10.1017/s0007114518002684.

Full text

Abstract:

AbstractEnergy restriction (ER) has been widely studied as a novel intervention, and its ability to prolong life has been fully demonstrated. For example, ER can significantly extend the lifespans of model flies, worms, rodents and other mammals. The role of ER in renal protection has also been elucidated. In preclinical studies, adjusting total energy intake or consumption of specific nutrients has prophylactic or therapeutic effects on ageing-related kidney disease and acute and chronic kidney injury. Amino acid restriction has gradually attracted attention. ER mimetics have also been studie

APA, Harvard, Vancouver, ISO, and other styles

27

Ruilope, Luis M., and Julian Segura. "Renal protection by antihypertensive therapy." Current Hypertension Reports 4, no. 4 (2002): 324–28. http://dx.doi.org/10.1007/s11906-996-0012-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Neumayer, Hans-Hellmut, Jürgen Gellert, and Friedrich Cameron Luft. "Calcium Antagonists and Renal Protection." Renal Failure 15, no. 3 (1993): 353–58. http://dx.doi.org/10.3109/08860229309054944.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Giovanna, Leoncini, Viazzi Francesca, and Pontremoli Roberto. "RAAS Inhibition and Renal Protection." Current Pharmaceutical Design 18, no. 7 (2012): 971–80. http://dx.doi.org/10.2174/138161212799436520.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Colson, P. "ACE inhibitors and renal protection." British Journal of Anaesthesia 78, no. 4 (1997): 477–78. http://dx.doi.org/10.1093/bja/78.4.477.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Zarbock, Alexander, and Kindgen Milles. "Novel therapy for renal protection." Current Opinion in Anaesthesiology 28, no. 4 (2015): 431–38. http://dx.doi.org/10.1097/aco.0000000000000213.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Epstein, Murray. "Calcium Antagonists and Renal Protection." Archives of Internal Medicine 152, no. 8 (1992): 1573. http://dx.doi.org/10.1001/archinte.1992.00400200011003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Patel, Pranav M., and Morton J. Kern. "Moving renal embolic protection forward." Catheterization and Cardiovascular Interventions 79, no. 3 (2012): 437–38. http://dx.doi.org/10.1002/ccd.24313.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Fukuda, M. "Antihypertensive Drugs and Renal Protection." JAMA: The Journal of the American Medical Association 289, no. 9 (2003): 1102—a—1103. http://dx.doi.org/10.1001/jama.289.9.1102-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Nespoux, Josselin, and Volker Vallon. "SGLT2 inhibition and kidney protection." Clinical Science 132, no. 12 (2018): 1329–39. http://dx.doi.org/10.1042/cs20171298.

Full text

Abstract:

Type 2 diabetes mellitus (T2DM) is a growing public health concern worldwide. Numerous drug classes are available for treatment, however, their efficacy with regard to diabetes-induced renal and cardiovascular (CV) complications remains limited. Inhibitors of the sodium-glucose cotransporter 2 (SGLT2) are a new class of blood glucose lowering medications that block renal glucose reabsorption and have protective effects on the kidney and the heart. This review focusses on the effects of SGLT2 inhibitors on the kidney and renal outcome: it briefly outlines renal glucose handling in diabetes and

APA, Harvard, Vancouver, ISO, and other styles

36

Joo, Jin Deok, Mihwa Kim, Patrick Horst, et al. "Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors." American Journal of Physiology-Renal Physiology 293, no. 6 (2007): F1847—F1857. http://dx.doi.org/10.1152/ajprenal.00336.2007.

Full text

Abstract:

We showed previously that activation of A1 adenosine receptors (AR) protects against renal ischemia-reperfusion (IR) injury in rats and mice. In the heart, transient A1AR activation produces biphasic protective effects: acute protection wanes after several hours but protective effects return 24–72 h later (second window of protection). In this study, we determined whether A1AR activation produces delayed renal protection and elucidated the mechanisms of acute and delayed renal protection. A1AR wild-type mice were subjected to 30-min renal ischemia and 24 h of reperfusion to produce acute renal

APA, Harvard, Vancouver, ISO, and other styles

37

Epstein, M. "Calcium antagonists and renal hemodynamics: implications for renal protection." Journal of the American Society of Nephrology 2, no. 2 (1991): S30. http://dx.doi.org/10.1681/asn.v22s30.

Full text

Abstract:

During the past decade, attention has focused on the effects of calcium antagonists on renal function. When administered in vitro to the isolated perfused kidney, calcium antagonists exhibit consistent actions permitting characterization of their renal effects. Calcium antagonists do not affect the vasodilated isolated perfused kidney, but they do dramatically alter the response of this preparation to vasoconstrictor agents. Our recent studies with the isolated perfused hydronephrotic rat kidney model, which permits visualization of afferent and efferent arterioles, have demonstrated that the

APA, Harvard, Vancouver, ISO, and other styles

38

Taal, Maarten W., and Barry M. Brenner. "Achieving maximal renal protection in nondiabetic chronic renal disease." American Journal of Kidney Diseases 38, no. 6 (2001): 1365–71. http://dx.doi.org/10.1053/ajkd.2001.29259.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Brown, W. Virgil. "Microvascular Complications of Diabetes Mellitus: Renal Protection Accompanies Cardiovascular Protection." American Journal of Cardiology 102, no. 12 (2008): 10L—13L. http://dx.doi.org/10.1016/j.amjcard.2008.09.068.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Barrios, Vivencio, and Carlos Escobar. "Canagliflozin: metabolic, cardiovascular and renal protection." Future Cardiology 17, no. 3 (2021): 443–58. http://dx.doi.org/10.2217/fca-2020-0192.

Full text

Abstract:

Patients with Type 2 Diabetes (T2D) are at risk of developing macrovascular (cardiac, cerebrovascular, peripheral arterial disease) and microvascular (nephropathy, neuropathy, retinopathy) complications. Glycemic control improves only microvascular outcomes. However, some SGLT-2 inhibitors and GLP1-R agonists have proven beneficial in macrovascular conditions. Canagliflozin is an SGLT2 inhibitor that provides sustained reductions in HbA1c, blood pressure and weight. Remarkably, as CANVAS program and CREDENCE trial demonstrated, canagliflozin promotes significant reductions in the frequency of

APA, Harvard, Vancouver, ISO, and other styles

41

Inoue, Tsuyoshi. "Neuroimmune system-mediated renal protection mechanisms." Clinical and Experimental Nephrology 25, no. 9 (2021): 915–24. http://dx.doi.org/10.1007/s10157-021-02062-3.

Full text

Abstract:

AbstractThe autonomic nervous system plays an important role in maintaining homeostasis in organisms. Recent studies have shown that it also controls inflammation by directly altering the function of the immune system. The cholinergic anti-inflammatory pathway (CAP) is one of the neural circuits operating through the vagus nerve. Acetylcholine released from the terminal of the vagus nerve, which is a parasympathetic nerve, acts on the α7 nicotinic acetylcholine receptor of macrophages and reduces inflammation in the body. Previous animal studies demonstrated that vagus nerve stimulation reduce

APA, Harvard, Vancouver, ISO, and other styles

42

Kobori, Hiroyuki, Hirohito Mori, Tsutomu Masaki, and Akira Nishiyama. "Angiotensin II Blockade and Renal Protection." Current Pharmaceutical Design 19, no. 17 (2013): 3033–42. http://dx.doi.org/10.2174/1381612811319170009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Meersch, Melanie, and Alexander Zarbock. "Renal protection in the 21st century." Current Opinion in Critical Care 22, no. 6 (2016): 554–59. http://dx.doi.org/10.1097/mcc.0000000000000352.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

BOWSHER, W. G., P. BLOTT, and H. N. WHITFIELD. "Radiation Protection in Percutaneous Renal Surgery." British Journal of Urology 69, no. 3 (1992): 231–33. http://dx.doi.org/10.1111/j.1464-410x.1992.tb15518.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Mah??, Emmanuel, Emmanuel Morelon, Jacques Fermanian, et al. "Renal-Transplant Recipients and Sun Protection." Transplantation 78, no. 5 (2004): 741–44. http://dx.doi.org/10.1097/01.tp.0000131818.24302.b8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Neumayer, Hans-Hellmut, and Ulrich Kunzendorf. "Renal Protection with the Calcium Antagonists." Journal of Cardiovascular Pharmacology 18 (1991): S11—S18. http://dx.doi.org/10.1097/00005344-199100181-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Bhattacharjee, Rabindra N., Sanjay V. B. Patel, Qizhi Sun, et al. "Renal Protection Against Ischemia Reperfusion Injury." Transplantation 104, no. 3 (2020): 482–89. http://dx.doi.org/10.1097/tp.0000000000002967.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Giannopoulos, Georgios, Dimitrios A. Vrachatis, Vasiliki Panagopoulou, Manolis Vavuranakis, Michael W. Cleman, and Spyridon Deftereos. "Remote Ischemic Conditioning and Renal Protection." Journal of Cardiovascular Pharmacology and Therapeutics 22, no. 4 (2017): 321–29. http://dx.doi.org/10.1177/1074248417702480.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Neumayer, Hans-Hellmut, and Ulrich Kunzendorf. "Renal Protection with the Calcium Antagonists." Journal of Cardiovascular Pharmacology 18 (1991): S11—S18. http://dx.doi.org/10.1097/00005344-199106181-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Wardle, Edwin N. "Renal protection in immunoglobulin-A nephropathy." Nephrology Dialysis Transplantation 21, no. 4 (2005): 1136. http://dx.doi.org/10.1093/ndt/gfi260.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!